Friday, 14th February

7:15AM - 8:15AM

Heritage Two

8:30AM - 10:30AM

Friday, 14th February

Novartis Lecture Theatre

Chair: Mark Guthridge

Deconstructing CML development - Emmanuelle Passegué
Megakaryocyte Pathology in Myeloproliferative Neoplasms - Wendy Erber
Inhibition of Telomerase Targets Leukaemia Stem Cells in MLL-rearranged Acute Myeloid Leukaemia (AML) - Steven Lane

10:30AM - 11:00AM

Friday, 14th February

11:00AM - 12:30PM

Friday, 14th February

Novartis Lecture Theatre

Chair: Peter Klinken

Thrombopoietin regulation of hematopoietic stem cells and megakaryopoiesis - Warren Alexander
Cavin-1 alters microvesicle content by modulating lipid raft-dependent trafficking to the plasma membrane. - Michelle M Hill
Investigating the role of familial cancer susceptibility loci in normal bone and bone cancer biology - Alvin JM Ng
Intronic Nonsense: hidden layers of gene expression control uncovered by studying granulopoiesis - John Rasko

12:30PM - 1:30PM

Friday, 14th February

Novartis Lecture Theatre

Chair: David Vaux

Raising the bar on preclinical cancer research (or how to identify the papers whose data just won't stand up). - C. Glenn Begley

1:30PM - 4:00PM

Friday, 14th February

Exhibition Hall

2:00PM - 3:30PM

Friday, 14th February

Heritage Two

4:00PM - 5:10PM

Friday, 14th February

Novartis Lecture Theatre

5:15PM - 6:15PM

Friday, 14th February

Novartis Lecture Theatre

Chair: Steven Lane

Curing Acute Promyelocytic Leukemia through therapy-induced PML/RARA degradation - Hugues de Thé

6:15PM - 7:30PM

Friday, 14th February

Seagrass Lawn

7:30PM - 10:00PM

Friday, 14th February

Exhibition Hall

Friday, 14th February 26th Lorne Cancer Conference 2014

Thermo Fisher Scientific Breakfast Industry Workshop

Session 3: Leukaemias I

Morning Tea

Session 4: Aberrant haemophoiesis

Special Lecture

Lunch

Metabolomics Australia Lunchtime Industry Workshop

Session 5: Nuclear receptors

Session 6: Plenary 2

Dinner

Poster Session 2